Dr. Michael John Wilkinson, MD

Dr. Wilkinson practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Wilkinson's NPI, 1699063701, was assigned on July 11, 2011. Dr. Wilkinson graduated from Drexel University College Of Medicine in 2011. Dr. Wilkinson holds California license A135918.

Dr. Wilkinson's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Wilkinson's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Wilkinson is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Wilkinson to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilkinson practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Wilkinson's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Wilkinson is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Wilkinson's licenses on file in 2 states: California and Illinois.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage, heart failure and heart valve disorders among the conditions Dr. Wilkinson treats.

CMS data shows 2,215 Medicare services from Dr. Wilkinson across 14 procedure codes in 2024, for 1,459 Medicare patients. Medicare paid $80,068 for them.

CMS counts 1,459 Medicare patients who saw Dr. Wilkinson in 2024. The largest group is 65 to 74, with 606 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wilkinson's median patient age at 64, with 43% women.

In 2024, Dr. Wilkinson wrote 2,444 Medicare Part D claims for 340 patients. 66% of them were for generic drugs. CMS names the drug for 2,260 of them, across 35 drugs with 11 or more claims each, at $763,085 in total drug cost. In 2023, CMS named 1,990 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Wilkinson for performance year 2024, reported as part of a group. Dr. Wilkinson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wilkinson as offering telehealth.

Dmand AI links 22 papers to Dr. Wilkinson, published from 2014 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors and Aortic Valve Stenosis. Dr. Wilkinson has published most often in J Clin Lipidol. Dr. Wilkinson's most frequent co-authors are Pam Rajendran Taub, MD, Gary S. Ma, MD and Harpreet Singh Bhatia, MAS, MD.

Dmand AI links Dr. Wilkinson to 1 clinical trial. Conditions studied include Hypertension and Vascular Diseases. Open Payments lists research payments to Dr. Wilkinson that name 1 trial.

CMS Open Payments shows 214 general payments to Dr. Wilkinson from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $72,615. It also lists 11 research payments totaling $205,253 from 2022 to 2025, naming 1 clinical trial.

Dr. Wilkinson graduated from Drexel University College Of Medicine in 2011.

Dr. Wilkinson is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.